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1. Introduction 
Schizophrenia is one of the most devastating psychiatric disorders. Schizophrenia affects 
1.1% of the population or 51 million people (NIMH). Schizophrenia is a disorder that affects 
multiple brain regions and systems. Symptoms include positive symptoms, negative 
symptoms and cognitive deficits. Much research has focused on two neurotransmitter 
systems, dopamine and glutamate. Postmortem studies examining morphology have found 
alterations in dendrites and spines in the prefrontal cortex and the hippocampus, changes in 
cell number in volume in the thalamus and alterations in protein expression in the 
prefrontal cortex. Genetic studies have found a number of genes associated with 
schizophrenia including but not limited to DISC1, neuregulin1, and Dysibindin 1. The 
current hypothesis based on the postmortem work and genetic studies suggests the etiology 
of schizophrenia has its origins in development. The changes in dendrites and spines 
observed in the prefrontal cortex and hippocampus without a change in cell number could 
occur as a result of alterations in calcium signaling levels in development due to alterations 
in synaptic input into the prefrontal cortex and hippocampus. The various genes that have 
been shown to be altered in schizophrenia are also involved in neurodevelopment. DISC1, 
neuroregulin 1 and Dysbindin 1 have all been shown to be involved in neurite outgrowth 
and differentiation (Ghiani et al, 2010; Kamiya et al, 2005; Pitcher et al, 2011; Sebat et al., 
2009; Wiliams et al., 2010). These data support the above hypothesis that schizophrenia is a 
neurodevelopmental disorder that may or may not have a genetic predisposition. In order to 
better understand the etiology of the disease, research needs good models with which to test 
theory. Genetic models, chemical lesions, and physical lesions have been used to produce 
animal models to mimic human disorders and are becoming the hallmark of translational 
research. Animal models in the past have been used to understand how the nervous system 
develops by using lesions to examine pathways or genetic knockouts to examine the role of 
genes in development and function of the nervous system. The use of animal models is not 
limited to basic research but is also used by pharmaceutical companies to test drugs to treat 
diseases to determine their viability. Whatever their use, animals provide us with a unique 
way in which to view how the nervous system develops, functions and what happens when 
development goes wrong. This chapter will focus on the use of animal models as a potential 
method to study neuropsychiatric disorders.  
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2. Animal models 
Over 50 animal models have been described in the past 30 years (Tseng et al., 2009). The first 
models tended to be pharmacological constructs linked to dopamine and glutamate. The 
issue with these models is that they leave out certain aspects of the disorder such as the idea 
that schizophrenia is a disorder founded in development, cognitive deficits as well as 
alterations in neuroanatomy and interactions between systems. A review by Harrision 
(2011) suggests that the problem with modeling schizophrenia is that since it is a disorder 
that involves so many brain regions, how does one choose a target for the lesion? 
Schizophrenia therefore, appears to be a disorder involving circuits (Fig 1). One way to 
choose a target is by picking a brain region shown to be altered anatomically or by choosing 
a gene whose expression is involved in the development of the structures shown to be 
altered in schizophrenia. With this in mind two of the most consistent postmortem findings 
in schizophrenia are lateral ventricular enlargement and a decrease in volume and cell 
number in the thalamic medial dorsal nucleus. Several models have been designed around 
these two findings and will be discussed in this chapter. The use of knock out mice to model 
schizophrenia has also been very popular. The mouse model for Dysbindin 1 has shown 
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3. Animal models involving the hippocampus 
Lesions of the ventral hippocampus in the rat involve using iobotinic acid to cause a 
bilateral excitotoxic lesion at postnatal day 7 (Lipska et al, 2002; Becker et al, 1999; Sams-
Dodd et al, 1997). One such model involves the neonatal damage of the rat ventral 
hippocampus; typically, ibotenic acid, causing an excitotoxic lesion, is applied to the 
ventral hippocampus at postnatal day 7 (Lipska et al 2002; Becker et al, 1999; Sams-Dodd 
et al, 1997). The animals are allowed to mature and are tested for social interactions 
(Sams-Dodd et al, 1997), aggression (Becker et al, 1999), and performance in working 
memory tasks (Lipska et al 2002). This model mimics a spectrum of behavioral features of 
schizophrenia; it produces functional pathology in other brain regions also implicated in 
schizophrenia, such as the striatum, the nucleus accumbens, and the prefrontal cortex 
(PFC). Furthermore, the social and functional effects are not evident until the rat subjects 
reach adolescence, thus mimicking the timing of onset of symptoms (for review see 
Lipska, 2004 and Tseng et al, 2009). Following the bilateral lesion at P7 the behaviors 
emerge in a manner consistent with schizophrenia. Negative symptoms such as 
aggression and deficits in grooming appear prior to puberty. The cognitive symptoms 
such as deficits in various types of memory appear at the onset of puberty and the 
positive symptoms appear late in adolescence (Tseng et al, 2009). This delayed emergence 
of behaviors mimics that observed in schizophrenia. This model appears to be consistent 
with many of the behavioral aspects of schizophrenia; however, it lacks construct validity, 
as schizophrenics do not have a lesion in their hippocampus similar to that seen in the 
model. Postmortem studies have reported morphometric abnormalities in the 
hippocampal formation, such as decreased volumes (Falkai & Bogerts, 1986; Heckers et al, 
1991) and decreased number of neurons and smaller pyramidal cells in schizophrenia 
(Falkai & Bogerts, 1986; Jonsson et al, 1999). Other studies have not been able to replicate 
such findings (Heckers et al, 1991; Walker et al, 2002). Further discrepancy is seen in the 
morphological evaluation of this model which reports an increase in synaptic density, 
number of branches, and dendritic length in the pyramidal cells of the PFC (Robinson and 
Kolb, 1997), which contradicts the compromised morphological evidence in schizophrenia 
(Byne W et al; 2001, Jones L, Mall N, Byne W; 1998, Bunney WE and Bunney BG; 2000, 
Schindler MK et al; 2002, Jonsson SAT et al; 1999; Broadbelt et al, 2002, Kalus, 2000; Black 
et al, 2004; Pierri et al, 2001; Garey et al, 1998; Glantz and Lewis, 2000). Although the 
discrepancy in anatomical findings between this model and schizophrenia are great, it 
prevails to be an attractive model because of its implications in the dopaminergic system, 
a neurotransmitter system known to be affected in this disorder and a major target for 
therapeutic agents. Recent investigations using this model examined cell excitability in 
PFC neurons, and it was concluded that the PFC dopamine-glutamate interactions were 
altered after puberty in the lesioned rats (Tseng et al, 2007). Specifically, the PFC neurons 
showed enhanced excitability in lesioned animals, which contradicts the common concept 
of hypofrontality, characteristic of schizophrenic subjects. While the model may have its 
inconsistencies, the approach using neurodevelopmental damage has merits in 
developing models for schizophrenia. 
The use of excitatory lesions of the entorhinal cortex (EC) has furthered investigation of the 
effects on the dopaminergic system. It was observed that an EC lesion resulted in the 
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enhancement of methamphetamine-induced dopamine release in the nucleus accumbens 
and basolateral amygdala (Uehara, et al 2007), implying dysregulation in the dopaminergic 
neurotransmission in the limbic regions. Although these models offer great insight into 
circuitry of the dopaminergic system and potential for development of therapeutic agents, it 
is evident that models based on manipulations of the dopamine system have limited 
promise. They can imitate a spectrum of schizophrenic behaviors, but they fall short on 
morphological and physiological findings. 
Keeping with the idea that schizophrenia is a disease that affects circuits, another 
mesiotemporal limbic area used for lesion studies is the amygadala. The amygdala receives 
projections from the hippocampus and projects to the nucleus accumbens (Fig. 1). A model 
put forward by Francine Benes examines the effects of altering the circuitry between the 
amygdala and the hippocampus. The non-competitive GABA-A receptor antagonist 
picrotoxin was infused into the basolateral complex of the amygdala. This was done to 
mimic a GABA defect in this region. This model shows alterations in GABAergic neurons in 
the CA2/3 region of the hippocampus similar to that seen in schizophrenia (Berretta and 
Benes 2006; Berretta et al, 2009). Daenen et al, (2001) examined several behaviors in rats 
following a lesion of the amygdala at P7 or P21. The lesions at P7 but not P21 showed 
alterations in locomotor stereotypy (Daenen et al, 2001) as well as play (Daenen et al, 2002) 
and exploratory activities (Woletrink et al, 2001). These lesion studies tend to find deficits in 
social behavior (Becker et al, 1999; Sams-Dodd et al, 1997), working memory (Lipska et al, 
2002), and abnormalities in locomotor stereotypy (Daenen et al 2001, 2003). Daenen et al, 
(2003) also lesioned the ventral hippocampus at P7 and P21 and examined the response to 
acoustic startle and found that the lesions had no effect on the response to acoustic startle. A 
final study examined the effect of a mesiotemporal limbic lesion on the expression NAA, a 
neuronal viability marker in the PFC, and they found a developmental effect in the early-
lesioned animals, which was absent from the animals lesioned as adults (Bertolino et al, 
1997). In humans, these temporal association areas have widespread connections with the 
medial dorsal nucleus of the thalamus and the pulvinar nucleus of the thalamus (Byne et al, 
2001), which has also been implicated in schizophrenia (Byne et al, 2002; 2001) (Fig. 2). When 
one looks at the brain regions involved in schizophrenia and the circuits involved, one 
target region emerges as a location to target in modeling schizophrenia, the medial dorsal 
nucleus of the thalamus. This nucleus receives multiple inputs from the hippocampus as 
well as the amygdala and projects to the prefrontal cortex as well as other regions involved 
in schizophrenia.  
4. Animal models and the thalamus 
Thalamic association nuclei, such as the medial dorsal nucleus (MD) (Paxinos G, 1986), 
which have connections to many regions involved in schizophrenia (Paxinos G, 1986; 
Kuroda et al, 1998), represents an important relevant target for lesion studies (see figure 2). 
Normal development of the cerebral cortex is dependent upon reciprocal connections with 
the thalamus. The close association between the MD and the PFC and EC initiates early in 
development. The cortical plate differentiates from a densely packed zone of immature cells 
into lamina, resembling future cortical layers (van Eden 1986); axons from early postmitotic  
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Fig. 2. Circuitry formed by the MD in rats. MD projects to cortex and receives feedback, as 
well as projections from subcortical structures. 
neurons of the cortical subplate pioneer the pathway from the cortex toward subcortical 
targets, prior to neurons from cortical layers V and VI migrating into position (Molnar 2000). 
By postnatal day 4 and 5, layer V can be distinguished from the upper cortical plate 
containing the elements to become layers II and III. The first evidence of retrograde labeling 
from PFC to MD becomes apparent at this time (Van Eden 1986). The arrival of the MD 
afferent fibers in the upper cortical plate precedes the completion of layer III differentiation, 
occurring on postnatal days 9 to 10 (Van Eden 1986). The predominant thalamic input to the 
PFC is from the medial dorsal nucleus (Negyess et al., 1998, Kuroda 1995a, 1995b). Afferents 
from the MD synapse on spines and dendritic shafts of pyramidal cells in the PFC (Negyess 
et al., 1998). Myelination of the axons from the MD to the PFC occurs approximately in the 
second decade of life (Molnar 2000). Developmental maturation of neurons is activity-
dependent (Van Pelt et al., 1996, Kossel et al., 1997, Baker et al., 1997); an early lesion of the 
MD could therefore result in abnormal development of the PFC. In particular, a decrease in 
thalamic input to PFC may result in decrease of calcium-mediated stimulation of dendritic 
remodeling. Binding of glutamate to the N-methyl-D-Aspartate (NMDA) receptor causes an 
influx of calcium, which triggers the release of calmodulin from the calcium binding protein 
neurogranin (Ramakers et al., 2001), allowing for calmodulin to bind to calcium. Calcium-
calmodulin can activate calcium calmodulin kinase (CaMK) II (Petit et al., 1998), CaM 
kinase, and CaM Kinases I and IV (Petit et al., 1998). CaMK II has been shown to be 
important in controlling spine formation (Petit et al., 1998), as well as neuronal arborization, 
both pre- and post-synaptically (Ramakers et al., 2001, Petit et al., 1998, Kater et al., 1988). 
CaMK II also phosphorylates MAP2, which in turn promotes dendritic branching. 
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Dephosphorylation of MAP2 by calcineurin promotes dendritic elongation (Ramakers et al., 
2001, Petit et al., 1998, Kater et al., 1988). Current postmortem studies of the PFC have 
shown a decrease in neurogranin and calmodulin in areas 9 and 32 (Broadbelt et al., 2006, 
2008). These data suggest possible alterations in calcium signaling in the PFC. Thus, changes 
in proteins involved in calcium signaling may lead to changes in dendritic arbors and 
spines, which are critical to neuronal function, leading to possible alterations in integration 
of synaptic inputs. Thus information transfer between cells can be altered. In addition, these 
data suggest that the medial dorsal nucleus is a potential target for a lesion during 
development that may result in alterations similar to those seen in schizophrenia.  
Research has shown that two of the most consistent findings in schizophrenia are volume 
and cell loss in the MD of the thalamus and enlarged anterior and posterior horns of the 
lateral ventricles (Pakkenberg; 1990, 1992, Popken et al 2000, Young et al 2000, Byne et al 
2001, 2002, Lewis et al 2001). Previous MD lesion studies have primarily looked at the effect 
of the lesions on behavior (Volk & Lewis 2003; Van Eden et al, 1994; Isseroff et al, 1982). 
Studies have shown that a lesion of the MD leads to impairments in spatial memory tasks in 
rats (Isseroff et al, 1982) as well as in monkeys (Aggleton et al., 1983). This spatial memory 
loss is qualitatively similar to that seen after damage of the prefrontal cortex (Isseroff et al, 
1982). MD lesions can also affect working memory as assessed by radial maze tests 
(Aggleton, 1983; Stokes1990). These findings are consistent with reports of working and 
spatial memory deficits in schizophrenic patients (Perry et al, 2001). An embryonic animal 
lesion model for schizophrenia includes intrauterine radiation of rhesus monkeys during 
thalamic neurogenesis, which results in a 25% loss of thalamic volume, neuron loss, and 
nonuniform damage to the thalamic complex (Schindler et al, 2002). Although this model is 
simulating the consistent finding of neuron loss and decreased volume in the thalamus 
(Pakkenberg; 1990, 1992, Popken et al 2000, Young et al 2000, Byne et al 2001, 2002, Lewis et 
al 2001), it offers too many variables as the entire fetus is subjected to radiation and thus a 
spectrum of possible side effects. Several studies showed alterations in working and short-
term memory in adult rats following early N-methyl-D-aspartate (NMDA) receptor 
inhibition in the MD (Garter et al., 1992, Sicar et al., 1998, 2003, Stefani et al., 2005, Wang et 
al., 2001 for review see Pehrson et al., 2007). 
Focusing on the relevant circuitry between the MD and the PFC, one study examined the 
structural and functional effects of a MD lesion on the PFC in the rat (Van Eden et al, 1998). 
A study using an electrothermal lesion on the MD on the day of birth analyzed prefrontal 
architecture on day 35, as well as performance on a delayed alternation task. They found no 
significant gross changes in the PFC, except for local decreases in cortical width. The 
behavioral ability in spatial task was also examining the morphology in the PFC; they only 
examined gross morphology and not specific cellular morphology, which is known to be 
affected in schizophrenic brains (Garey et al, 1998; Broadbelt et al, 2002; Glantz & Lewis 
2000). When using animals as models it is important to understand timing of developmental 
events. In rats, thalamic fibers grow into the cortex between postnatal day 0 and 7 (Wise et 
al, 1979), and a lesion performed too early may reflect the plastic ability of the brain. An 
additional MD lesion study looked at whether an acute excitotoxic lesion of the MD on 
periadolescent monkeys could produce decreased PFC glutamate decarboxylase mRNA 
expression (Volk & Lewis, 2003). They found that a substantial lesion did not reduce levels 
of this GABA-synthesizing enzyme in the PFC four weeks after lesions were performed 
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(Volk & Lewis, 2003). Their inability to see a change in PFC enzymatic levels may have 
occurred as a result of the acute lesion in prepubescent animals. The connections between 
the MD and the PFC may have been well established by the time the lesions were 
performed, therefore, may not accurately reflect the development. Our laboratory is 
currently developing an animal model for prefrontal cortical development. Our model is 
based on the interplay between the prefrontal cortex and the MD and that pyramidal cell 
development is activity dependent. Our data suggest that the model may also model some 
of the morphological alterations seen in the prefrontal cortex, such as loss of dendrites and 
spines, and in the hippocampus, such as change in cell density in CA1. Further work 
examining behavior needs to be performed to more accurately characterize the model as 
having relevance for studying schizophrenia. 
5. Conclusion 
While many of the models discussed reflect the ability to express multiple symptoms of 
schizophrenia from behavior to genetics to morphology, none of the models appear to 
mimic all of the symptoms. A current review article by Harrison et al., (2011) suggests that 
the complexity of the disorder makes it very difficult to accurately model schizophrenia. The 
authors question how you choose your target for alteration when so many targets appear 
possible. The point is a valid one, as schizophrenia does not present itself the same way in 
all individuals. Schizophrenia has many symptoms that can be grouped into three 
categories: positive, negative and cognitive. Schizophrenics may have symptoms from 1, 2 
or all 3 categories. Therefore, it may be very difficult to have one model for all of the 
symptoms exhibited in schizophrenia. Instead several models may need to be used to 
understand how schizophrenia manifests itself. What does seem to be consistent in all of the 
research is the agreement that schizophrenia manifests itself during development, which 
leads to behavioral alterations in late adolescence and early adulthood that may or may not 
progress throughout the rest of the individual’s life. While one model may not fit all of the 
symptoms of schizophrenia, it may model enough aspects to help us understand how the 
disease manifests itself and eventually help us come up with better treatments for a complex 
disorder which affects over 50 million people. 
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